Home > Balance Sheet > AUROBINDO PHARMA

AUROBINDO PHARMA
Net Current Assets

    Back to Balance Sheet
AUROBINDO PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for AUROBINDO PHARMA
Please provide your vote to see the results

AUROBINDO PHARMA Last 5 Year Net Current Assets History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Net Current Assets (Including Current Investments) ₹12,480 Cr₹11,573 Cr₹9,966 Cr₹9,888 Cr₹9,075 Cr

What is the latest Net Current Assets ratio of AUROBINDO PHARMA ?

The latest Net Current Assets ratio of AUROBINDO PHARMA is ₹12,480 Cr based on Mar2025 Consolidated results.
Year Net Current Assets
Mar2025₹12,480 Cr
Mar2024₹11,573 Cr
Mar2023₹9,966 Cr
Mar2022₹9,888 Cr
Mar2021₹9,075 Cr

How is Net Current Assets of AUROBINDO PHARMA Trending?

Years Net Current Assets % Change
Mar2025 ₹12,480 Cr
7.84
Mar2024 ₹11,573 Cr
16.12
Mar2023 ₹9,966 Cr
0.79
Mar2022 ₹9,888 Cr
8.96
Mar2021 ₹9,075 Cr -

Compare Net Current Assets of peers of AUROBINDO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AUROBINDO PHARMA ₹70,271.0 Cr 1.4% -1.9% -4.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹418,768.0 Cr -2.7% -2.2% -0.8% Stock Analytics
DIVIS LABORATORIES ₹169,385.0 Cr -0.7% -1.1% 7.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹127,242.0 Cr -0.8% 0.8% 12.2% Stock Analytics
CIPLA ₹121,093.0 Cr -1.2% -1.8% 3.4% Stock Analytics
DR REDDYS LABORATORIES ₹106,799.0 Cr NA 2.4% 0.2% Stock Analytics


AUROBINDO PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
AUROBINDO PHARMA

1.4%

-1.9%

-4.2%

SENSEX

-0.4%

-0.2%

2.9%


You may also like the below Video Courses